Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACE. Lu H, Liang B, Zheng C, Xia X, et al. BMC Gastroenterol 2025;25:817.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu H, Liang B, Zheng C, Xia X, et al. Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACE. BMC Gastroenterol 2025;25:817.
PMID: 41257572